Centene
CNC

$73.10

8.46%

Market Cap: 39B

About: Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Employees: 67,700

Financials Hospital & Medical Service Plans

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 21 analysts

0

News positive %

of 24 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

36% more call options, than puts

Call options by funds: $196M | Put options by funds: $144M

31% more first-time investments, than exits

New positions opened: 110 | Existing positions closed: 84

30% more repeat investments, than reductions

Existing positions increased: 373 | Existing positions reduced: 288

6% more capital invested

Capital invested by funds: $37.2B [Q4 2023] → $39.3B (+$2.08B) [Q1 2024]

3% more funds holding

Funds holding: 876 [Q4 2023] → 902 (+26) [Q1 2024]

0.14% less ownership

Funds ownership: 93.8% [Q4 2023] → 93.65% (-0.14%) [Q1 2024]

40% less funds holding in top 10

Funds holding in top 10: 15 [Q4 2023] → 9 (-6) [Q1 2024]

See Fund Rankings

Research analyst outlook

21 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$69

6%

downside

Avg. target

$89

22%

upside

High target

$110

50%

upside

21 analyst ratings

14 positive

67%

7 neutral

33%

0 negative

0%

TD Cowen Gary Taylor	9%upside $80	Buy Maintained	24 Jul 2024
Jefferies David Windley	6%downside $69	Hold Downgraded	24 Jul 2024
Cantor Fitzgerald Sarah James	23%upside $90	Overweight Reiterated	23 Jul 2024
Wells Fargo Stephen Baxter	11%upside $81	Overweight Maintained	22 Jul 2024
Truist Securities Ryan MacDonald	22%upside $89	Buy Maintained	15 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 24 articles about CNC published over the past 30 days

Centene Beats Estimates, Boosts Guidance on Higher Premiums, Memberships

Centene (CNC) shares jumped in intraday trading Friday as the managed care provider reported better-than-expected profit and sales and raised its guidance as its premium and services sales and members increased.

Centene Beats Estimates, Boosts Guidance on Higher Premiums, Memberships

Zacks Investment Research

Centene (CNC) Q2 Earnings Miss on Declining Medicaid Membership

Centene's (CNC) second-quarter earnings suffer from rising operating expenses and a decline in Medicaid membership levels. Improved Marketplace membership growth partially offset the negatives.

Centene (CNC) Q2 Earnings Miss on Declining Medicaid Membership

Centene Corporation (CNC) Q2 2024 Earnings Call Transcript

Centene Corporation. (NYSE:CNC ) Q2 2024 Earnings Conference Call July 26, 2024 8:30 AM ET Company Participants Jennifer Gilligan - SVP, Finance and Investor Relations Sarah London - Chief Executive Officer Andrew Asher - EVP and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Josh Raskin - Nefron Research A.J.

Centene Corporation (CNC) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Centene (CNC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Centene (CNC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Health Insurer Centene's Q2 Premium Revenue Cushions Fall In Medicaid Enrollment, Raises Annual Outlook

On Friday, Centene Corporation CNC reported second-quarter sales of $39.84 billion, up 5.9% year-over-year, beating the consensus of $36.46 billion.

Health Insurer Centene's Q2 Premium Revenue Cushions Fall In Medicaid Enrollment, Raises Annual Outlook

Zacks Investment Research

Centene (CNC) Q2 Earnings Miss Estimates

Centene (CNC) came out with quarterly earnings of $2.42 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.10 per share a year ago.

Centene (CNC) Q2 Earnings Miss Estimates

Centene Profits Hit $1.1 Billion As Obamacare Offsets Drop In Medicaid

Centene reported second quarter profits of $1.1 billion as Obamacare enrollment and premium revenue helped overcome a big dip in Medicaid enrollment.

Centene Profits Hit $1.1 Billion As Obamacare Offsets Drop In Medicaid

Centene beats profit estimates after change in govt risk adjustment

Centene Corp beat Wall Street estimates for second-quarter profit on Friday following the company's announcement that it was no longer required to make a $1.3 billion payment related to its government-sponsored Medicaid offerings.

Centene beats profit estimates after change in govt risk adjustment

CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS

-- Diluted E PS of $2.16; Adjusted Diluted EPS of $2.42 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42 , up 15% from $2.10 in the second quarter of 2023. Premium and service revenues of $36.0 billion in the second quarter of 2024.

CENTENE CORPORATION REPORTS SECOND QUARTER 2024 RESULTS

Zacks Investment Research

3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments

Rising premiums, technological advancements and increased demand for Medicare plans are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI and CNC are poised to benefit from encouraging industry prospects.

3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments

See News Rankings